VOGLIBOSE;3,4-DIDEOXY-4-[[2-HYDROXY-1-(HYDROXYMETHYL)ETHYL]AMINO]-2-C-(HYDROXYMETHYL)-D-EPIINOSITOL;3,4-DIDEOXY-4-[[2-HYDROXY-1-(HYDROXYMETHYL)ETHYL]AMINO]-2-C-(HYDROXYMETHYL)-D-EPINOSITOL;5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol;VOGLIBOSE, 99+%;A 71100;AO 128;Basen
Voglibose is an alpha-glucosidase inhibitor used for managing type 2 diabetes. It is synthesized via chemical fermentation processes to block carbohydrate absorption in the intestine. The compound features the molecular formula C18H33NO9 and CAS number 76715-45-2.
Contraindicated in patients with inflammatory bowel disease or intestinal obstruction. Store in a cool, dry place below 25°C away from direct sunlight. Personnel must wear protective gear during handling to avoid inhalation or skin contact.